Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Pohl

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Radiology|November 28, 2008
Subtraction MR images in a multiple sclerosis multicenter clinical trial settingBastiaan Moraal, Dominik S Meier, Peter A Poppe, et al.
Archives of Neurology|September 12, 2007
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year resultsFrederik Barkhof, Chris H Polman, Ernst-Wilhelm Radue, et al.
JAMA Neurology|January 22, 2014
Vitamin D as an early predictor of multiple sclerosis activity and progressionAlberto Ascherio, Kassandra L Munger, Rick White, et al.
Plos One|May 29, 2019
New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II studyMatthias Englbrecht, Rieke Alten, Martin Aringer, et al.
The Lancet. Neurology|November 3, 2009
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk scorePhilip L De Jager, Lori B Chibnik, Jing Cui, et al.
Journal of Neuroinflammation|June 19, 2012
Variability in detection and quantification of interferon β-1b-induced neutralizing antibodiesHans-Peter Hartung, Bernd Kieseier, Douglas S Goodin, et al.
Arthritis Care & Research|August 3, 2016
Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated ChallengeMatthias Englbrecht, Rieke Alten, Martin Aringer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2018
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trialsDorothea Buck, Till Fm Andlauer, Wilmar Igl, et al.
The Journal of Rheumatology|February 17, 2015
Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group PlenarySusan J Bartlett, Vivian P Bykerk, Roxanne Cooksey, et al.
The Journal of Rheumatology|March 4, 2014
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare WorkshopVivian P Bykerk, Elisabeth Lie, Susan J Bartlett, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Radiology|November 28, 2008
Subtraction MR images in a multiple sclerosis multicenter clinical trial settingBastiaan Moraal, Dominik S Meier, Peter A Poppe, et al.
Archives of Neurology|September 12, 2007
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year resultsFrederik Barkhof, Chris H Polman, Ernst-Wilhelm Radue, et al.
JAMA Neurology|January 22, 2014
Vitamin D as an early predictor of multiple sclerosis activity and progressionAlberto Ascherio, Kassandra L Munger, Rick White, et al.
Plos One|May 29, 2019
New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II studyMatthias Englbrecht, Rieke Alten, Martin Aringer, et al.
The Lancet. Neurology|November 3, 2009
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk scorePhilip L De Jager, Lori B Chibnik, Jing Cui, et al.
Journal of Neuroinflammation|June 19, 2012
Variability in detection and quantification of interferon β-1b-induced neutralizing antibodiesHans-Peter Hartung, Bernd Kieseier, Douglas S Goodin, et al.
Arthritis Care & Research|August 3, 2016
Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated ChallengeMatthias Englbrecht, Rieke Alten, Martin Aringer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2018
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trialsDorothea Buck, Till Fm Andlauer, Wilmar Igl, et al.
The Journal of Rheumatology|February 17, 2015
Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group PlenarySusan J Bartlett, Vivian P Bykerk, Roxanne Cooksey, et al.
The Journal of Rheumatology|March 4, 2014
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare WorkshopVivian P Bykerk, Elisabeth Lie, Susan J Bartlett, et al.
Pageof 7